- Brand Name: Natdac
- Content: Daclatasvir
- Manufactured by: Natco Pharma Ltd.
- Strengths: 60 mg
- Form: Tablets
- Packing: Pack of 28 Tablets
- Shipping: Worldwide
We are LeadingSuppliersExportersDistributorsSellersHepatitis C/B, Anticancer medicine, HIV medicines Worldwide
NATDAC 60 MG TABLET
Natdac is a tablet composition of Daclatasvir which is an antiviral medicine that prevents hepatitis C virus (HCV) from multiplying in your body.
USE OF NATDAC 60 MG TABLET
Daclatasvir under the name Natdac is used with another antiviral medication (sofosbuvir) to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. These medications together reduce the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.
POSSIBLE SIDE-EFFECTS OF NATDAC 60 MG TABLET
Tiredness, headache, nausea, or diarrhea may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly.
A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling, severe dizziness, trouble breathing.
- Brand Name Natdac
- Content Daclatasvir Dihydrochloride
- Manufactured by Natco Pharma
- Strengths 30mg and 60 mg
- Form Tablets
- Packing Pack of 28 Tablets
Natdac (Daclatasvir Dihydrochloride) is a treatment for chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection. It is always prescribed with sofosbuvir.
Natdac contains the active ingredient Daclatasvir. Daclatasvir is used with other antiviral medicines in the treatment chronic hepatitis C infection of genotype 1.